biotech
biotech Articles
Conatus Pharmaceuticals shares were more than halved on Thursday after the company announced top-line results from its midstage trial in cirrhosis patients.
Published:
Last Updated:
Clovis Oncology shares jumped on Tuesday after the European Patent Office upheld the company’s claims.
Published:
Last Updated:
Global Blood Therapeutics shares shot up on Monday after the company announced that it received an update from the FDA in regards to its sickle cell disease treatment.
Published:
Last Updated:
Vanda Pharmaceuticals shares made a solid gain on Monday after the firm announced results from a midstage trial of patients with idiopathic and diabetic gastroparesis.
Published:
Last Updated:
Tonix Pharmaceuticals shares were up sharply on Thursday after the company announced an update from the FDA.
Published:
Last Updated:
Transformative medicines company Moderna intends to price more than 21 million shares for an initial public offering valued up to $600 million.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
Catabasis Pharmaceuticals shares made a handy gain on Tuesday after the company announced early stage data from its Duchenne muscular dystrophy study.
Published:
Last Updated:
Rocket Pharmaceuticals shares dipped on Tuesday after the company gave an update from the FDA. While the update wasn’t negative, this seems to be a case of sell the news, as the stock is up 65% in...
Published:
Last Updated:
Despite this crushing loss where we saw shares down about 41% on Monday, one analyst is still positive on the stock.
Published:
Last Updated:
Zafgen shares were absolutely crushed on Monday after the company announced an update from the FDA.
Published:
Last Updated:
Mallinckrodt has been a prominent player in the health care industry and while most analysts are taking a middle-of-the-road approach to the company, one has come out with a very bullish report.
Published:
Last Updated:
Here 24/7 Wall St. takes a look at a recent report by Canaccord Genuity regarding to biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest...
Published:
Last Updated:
Seattle Genetics shares dipped on Monday following an update from the FDA on Adcetris for certain lymphomas.
Published:
Last Updated:
Arena Pharmaceuticals shares jumped early on Thursday after the company announced a new global license agreement with United Therapeutics.
Published:
Last Updated: